InsiderTrades.com logo

SUPN Insider Trading

Insider Ownership Percentage: 8.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $23,569,700.10

Supernus Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Supernus Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Supernus Pharmaceuticals Share Price & Price History

Current Price: $47.76
Price Change: ▼ Price Decrease of -1.08 (-2.21%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for SUPN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Supernus Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/18/2026Padmanabh P. BhattVPSell7,250$49.60$359,600.0017,044View SEC Filing Icon  
3/16/2026Padmanabh P. BhattVPSell50,000$50.28$2,514,000.0017,044View SEC Filing Icon  
3/13/2026Jack A. KhattarCEOSell35,000$50.37$1,762,950.00958,100View SEC Filing Icon  
3/12/2026Frederick M. HudsonDirectorSell5,369$50.61$271,725.0960,413View SEC Filing Icon  
3/6/2026Georges GemayelDirectorSell8,787$53.00$465,711.0027,277View SEC Filing Icon  
3/5/2026Georges GemayelDirectorSell10,000$53.71$537,100.0028,159View SEC Filing Icon  
2/19/2026Bethany SensenigDirectorSell4,475$51.01$228,269.75View SEC Filing Icon  
12/19/2025Frank MottolaSVPSell20,000$50.41$1,008,200.0015,496View SEC Filing Icon  
12/18/2025Padmanabh P. BhattVPSell710$44.44$31,552.4014,508View SEC Filing Icon  
10/9/2025Jack A. KhattarCEOSell59,900$50.57$3,029,143.001,206,578View SEC Filing Icon  
9/29/2025Jack A. KhattarCEOSell10,235$48.02$491,484.701,144,336View SEC Filing Icon  
9/23/2025Jack A. KhattarCEOSell29,513$47.23$1,393,898.991,140,883View SEC Filing Icon  
9/22/2025Jack A. KhattarCEOSell16,587$47.02$779,920.741,122,456View SEC Filing Icon  
9/12/2025Frank MottolaSVPSell5,000$45.87$229,350.0015,496View SEC Filing Icon  
9/8/2025Jack A. KhattarCEOSell6,322$46.29$292,645.381,111,983View SEC Filing Icon  
9/5/2025Jack A. KhattarCEOSell55,578$46.01$2,557,143.781,110,231View SEC Filing Icon  
8/25/2025Frank MottolaSVPSell14,000$44.51$623,140.0015,496View SEC Filing Icon  
8/25/2025Jack A. KhattarCEOSell1,000$45.00$45,000.001,071,459View SEC Filing Icon  
8/22/2025Timothy C DecCFOSell11,780$44.49$524,092.201,246View SEC Filing Icon  
8/14/2025Bethany SensenigDirectorSell5,369$42.25$226,840.25View SEC Filing Icon  
8/14/2025Frederick M. HudsonDirectorSell7,457$42.26$315,132.8246,307View SEC Filing Icon  
8/6/2025Jack A. KhattarCEOSell140,000$42.02$5,882,800.001,030,183View SEC Filing Icon  
2/21/2025Jonathan RubinSVPSell927$39.15$36,292.057,853View SEC Filing Icon  
2/4/2025Padmanabh P. BhattVPSell9,477$39.70$376,236.9010,149View SEC Filing Icon  
1/28/2025Padmanabh P. BhattVPSell700$39.62$27,734.0010,149View SEC Filing Icon  
11/7/2024Frank MottolaSVPSell15,000$36.98$554,700.008,200View SEC Filing Icon  
11/7/2024Georges GemayelDirectorSell14,213$36.62$520,480.0613,315View SEC Filing Icon  
11/7/2024Jack A. KhattarCEOSell125,000$36.68$4,585,000.00926,172View SEC Filing Icon  
3/21/2024Padmanabh P. BhattVPSell14,491$35.31$511,677.218,570View SEC Filing Icon  
3/19/2024Padmanabh P. BhattVPSell12,364$35.31$436,572.848,570View SEC Filing Icon  
3/12/2024Padmanabh P. BhattVPSell3,884$32.99$128,133.168,570View SEC Filing Icon  
2/26/2024Padmanabh P. BhattVPSell5,000$30.21$151,050.008,570View SEC Filing Icon  
1/10/2024Tami Tillotson MartinVPSell8,000$27.91$223,280.0085,664View SEC Filing Icon  
11/15/2023Frederick M. HudsonDirectorSell9,093$28.50$259,150.5033,231View SEC Filing Icon  
11/14/2023Frank MottolaSVPSell1,110$28.13$31,224.305,681View SEC Filing Icon  
8/30/2023Tami Tillotson MartinVPSell8,100$32.00$259,200.0085,249View SEC Filing Icon  
8/25/2023Tami Tillotson MartinVPSell5,135$31.59$162,214.6585,249View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Supernus Pharmaceuticals (NASDAQ:SUPN)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SUPN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Supernus Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/17/2026Rockefeller Capital Management L.P.846$42K0.0%+354.8%0.001%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC4,767$0.24M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/25/2026Sit Investment Associates Inc.65,200$3.24M0.1%+0.4%0.114%Search for SEC Filing on Google Icon
2/24/2026Villanova Investment Management Co LLC48,054$2.39M1.7%-12.4%0.084%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.395,761$19.67M0.0%+9.4%0.690%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC4,767$0.24M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV8,242$0.41M0.0%-10.9%0.014%Search for SEC Filing on Google Icon
2/18/2026State of Tennessee Department of Treasury15,490$0.75M0.0%-28.4%0.027%Search for SEC Filing on Google Icon
2/18/2026Krensavage Asset Management LLC313,499$15.58M5.5%-13.8%0.547%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp4,480$0.22M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/18/2026Zacks Investment Management36,349$1.81M0.0%N/A0.063%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP23,347$1.16M0.0%-1.8%0.041%Search for SEC Filing on Google Icon
2/18/2026SummitTX Capital L.P.11,670$0.58M0.0%+2.7%0.020%Search for SEC Filing on Google Icon
2/18/2026Susquehanna Portfolio Strategies LLC142,182$7.07M0.1%-8.6%0.248%Search for SEC Filing on Google Icon
2/18/2026Tudor Investment Corp ET AL33,247$1.65M0.0%+10.8%0.058%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd5,385$0.27M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/18/2026Odyssean LLC14,738$0.73M0.5%N/A0.026%Search for SEC Filing on Google Icon
2/18/2026Man Group plc31,097$1.55M0.0%-67.3%0.054%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC23,254$1.16M0.0%-67.6%0.041%Search for SEC Filing on Google Icon
2/18/2026Elmind Capital LP20,000$0.99M0.3%N/A0.035%Search for SEC Filing on Google Icon
2/18/2026Catalio Capital Management LP257,465$12.80M2.4%-10.3%0.449%Search for SEC Filing on Google Icon
2/18/2026Aristotle Capital Boston LLC234,503$11.66M0.6%-23.2%0.409%Search for SEC Filing on Google Icon
2/18/2026Bridgeway Capital Management LLC58,000$2.88M0.1%-38.0%0.101%Search for SEC Filing on Google Icon
2/18/2026Armistice Capital LLC2,764,000$137.37M1.6%-2.5%4.820%Search for SEC Filing on Google Icon
2/17/2026Freestone Grove Partners LP196,318$9.76M0.1%N/A0.342%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC29,742$1.48M0.1%+106.3%0.052%Search for SEC Filing on Google Icon
2/17/2026PDT Partners LLC76,673$3.81M0.2%-13.1%0.134%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC126,230$6.27M0.0%-7.5%0.220%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers5,135$0.26M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC123,291$6.13M0.0%N/A0.215%Search for SEC Filing on Google Icon
2/17/2026Quantedge Capital Pte Ltd89,600$4.45M2.1%-26.0%0.156%Search for SEC Filing on Google Icon
2/17/2026Amundi20,959$1.04M0.0%+107.4%0.037%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD52,786$2.62M0.0%+5.8%0.092%Search for SEC Filing on Google Icon
2/17/2026Weiss Asset Management LP39,971$1.99M0.0%N/A0.070%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.88,070$4.38M0.0%+40.9%0.154%Search for SEC Filing on Google Icon
2/17/2026Maryland State Retirement & Pension System8,351$0.42M0.0%+3.6%0.015%Search for SEC Filing on Google Icon
2/17/2026Atom Investors LP4,516$0.22M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board64,637$3.21M0.0%+85.5%0.113%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP229,126$11.39M0.1%N/A0.400%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada6,987$0.35M0.0%+5.4%0.012%Search for SEC Filing on Google Icon
2/17/2026Ashford Capital Management Inc.612,538$30.44M3.4%+8.7%1.068%Search for SEC Filing on Google Icon
2/17/2026Rice Hall James & Associates LLC467,886$23.25M1.3%-1.7%0.816%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC92,447$4.60M0.0%+37.4%0.161%Search for SEC Filing on Google Icon
2/16/2026Sofinnova Investments Inc.553,095$27.49M1.1%+46.7%0.965%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC12,501$0.62M0.0%+169.5%0.022%Search for SEC Filing on Google Icon
2/16/2026Fieldview Capital Management LLC4,874$0.24M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC109,457$5.44M0.0%-52.7%0.191%Search for SEC Filing on Google Icon
2/16/2026Bridge City Capital LLC63,801$3.17M0.9%-12.4%0.111%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC5,456$0.27M0.0%-27.0%0.010%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 25,802$1.28M0.0%-4.4%0.045%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co48,160$2.39M0.0%-21.1%0.084%Search for SEC Filing on Google Icon
2/13/2026Segall Bryant & Hamill LLC23,233$1.16M0.0%+35.5%0.041%Search for SEC Filing on Google Icon
2/13/2026Walleye Capital LLC28,697$1.43M0.0%N/A0.050%Search for SEC Filing on Google Icon
2/13/2026Advisory Research Inc.19,975$0.99M0.1%+4.8%0.035%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp50,380$2.50M0.0%-19.7%0.088%Search for SEC Filing on Google Icon
2/13/2026Commerce Bank13,331$0.66M0.0%-5.8%0.023%Search for SEC Filing on Google Icon
2/13/2026Morgan Stanley1,079,471$53.65M0.0%+42.9%1.883%Search for SEC Filing on Google Icon
2/13/2026Schroder Investment Management Group189,942$9.48M0.0%N/A0.331%Search for SEC Filing on Google Icon
2/13/2026Jacobs Levy Equity Management Inc.126,217$6.27M0.0%+222.2%0.220%Search for SEC Filing on Google Icon
2/13/2026Public Sector Pension Investment Board198,406$9.86M0.0%-9.3%0.346%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC5,065$0.25M0.0%+8.2%0.009%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP29,804$1.48M0.0%-57.9%0.052%Search for SEC Filing on Google Icon
2/13/2026Headlands Technologies LLC22,473$1.12M0.1%+387.3%0.039%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.703,625$34.97M0.0%-3.9%1.227%Search for SEC Filing on Google Icon
2/13/2026Police & Firemen s Retirement System of New Jersey14,298$0.71M0.0%-6.7%0.025%Search for SEC Filing on Google Icon
2/13/2026State Street Corp2,219,228$110.30M0.0%+1.4%3.870%Search for SEC Filing on Google Icon
2/13/2026Victory Capital Management Inc.526,220$26.15M0.0%-6.0%0.918%Search for SEC Filing on Google Icon
2/13/2026Vontobel Holding Ltd.4,349$0.22M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/13/2026Martingale Asset Management L P58,268$2.90M0.1%-2.8%0.102%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN61,072$3.04M0.0%+46.2%0.107%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP29,510$1.47M0.0%-67.9%0.051%Search for SEC Filing on Google Icon
2/12/2026Brooklyn Investment Group3,916$0.20M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/12/2026Orion Porfolio Solutions LLC11,655$0.58M0.0%-5.5%0.020%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC303,716$15.10M0.1%+842.4%0.530%Search for SEC Filing on Google Icon
2/12/2026Commonwealth Equity Services LLC10,376$0.52M0.0%+22.6%0.018%Search for SEC Filing on Google Icon
2/12/2026State Board of Administration of Florida Retirement System59,632$2.96M0.0%-7.8%0.104%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC1,732,522$86.11M0.1%-0.5%3.021%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP2,712,341$134.80M0.0%-9.6%4.730%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.3,472$0.17M0.0%+36.4%0.006%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc5,190$0.26M0.0%-65.5%0.009%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund44,472$2.21M0.0%+33.5%0.078%Search for SEC Filing on Google Icon
2/12/2026Campbell & CO Investment Adviser LLC6,151$0.31M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/12/2026Loomis Sayles & Co. L P1,448,842$72.01M0.1%+12.7%2.527%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank110,600$5.50M0.0%+1.9%0.193%Search for SEC Filing on Google Icon
2/12/2026Great Lakes Advisors LLC52,614$2.62M0.0%-26.1%0.092%Search for SEC Filing on Google Icon
2/12/2026NDVR Inc.4,873$0.24M0.2%+12.7%0.008%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC110,790$5.51M0.0%-61.3%0.193%Search for SEC Filing on Google Icon
2/12/2026SmartHarvest Portfolios LLC4,922$0.25M0.1%N/A0.009%Search for SEC Filing on Google Icon
2/11/2026Illinois Municipal Retirement Fund29,924$1.49M0.0%+4.8%0.052%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG113,319$5.63M0.0%+0.9%0.198%Search for SEC Filing on Google Icon
2/11/2026Axiom Investors LLC DE106,185$5.28M0.0%+1.5%0.185%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC17,491$0.87M0.0%+142.5%0.031%Search for SEC Filing on Google Icon
2/11/2026Franklin Resources Inc.91,018$4.52M0.0%-4.6%0.159%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.251,756$12.51M0.0%+47.0%0.439%Search for SEC Filing on Google Icon
2/11/2026Los Angeles Capital Management LLC7,505$0.37M0.0%-60.9%0.013%Search for SEC Filing on Google Icon
2/11/2026Vestcor Inc3,405$0.17M0.0%+142.3%0.006%Search for SEC Filing on Google Icon
2/11/2026State of Wyoming6,641$0.33M0.0%+366.7%0.012%Search for SEC Filing on Google Icon
2/10/2026AdvisorShares Investments LLC28,394$1.41M0.2%+82.9%0.050%Search for SEC Filing on Google Icon
2/10/2026Norges Bank120,396$5.98M0.0%N/A0.210%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC61,531$3.06M0.0%+72.3%0.107%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Supernus Pharmaceuticals logo
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. The company's commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset seizures in adults and children between 6 to 17 years of age. It also offers comprise Qelbree, a novel non-stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in adults and pediatric patients 6 years and older; APOKYN for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO for treating levodopa/carbidopa in patients with PD experiencing off episodes; MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults; GOCOVRI for the treatment of dyskinesia in patients with PD; and Osmolex ER for the treatment of Parkinson's disease and drug-induced extrapyramidal reaction in adult patients. In addition, the company's product candidates include SPN-830, a late-stage drug/device combination product candidate for the treatment of off episodes in PD patients; SPN-817, a novel first-in-class selective acetylcholinesterase inhibitor, which is in Phase II clinical trials for the treatment of epilepsy; SPN-820, a product candidate in Phase II clinical trials for treating resistant depression; SPN-443, a preclinical product for the treatment of ADHD/CNS; and SPN-446 for narcolepsy and SPN-448 for the treatment of CNS which is in discovery stage. It markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. Supernus Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Rockville, Maryland.
Read More on Supernus Pharmaceuticals

Today's Range

Now: $47.76
Low: $46.83
High: $49.29

50 Day Range

MA: $51.11
Low: $47.76
High: $56.32

52 Week Range

Now: $47.76
Low: $29.16
High: $59.68

Volume

1,279,868 shs

Average Volume

861,856 shs

Market Capitalization

$2.75 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.7

Who are the company insiders with the largest holdings of Supernus Pharmaceuticals?

Supernus Pharmaceuticals' top insider investors include:
  1. Jack A Khattar (CEO)
  2. Frederick M Hudson (Director)
  3. Georges Gemayel (Director)
  4. Padmanabh P Bhatt (VP)
  5. Frank Mottola (SVP)
  6. Jonathan Rubin (SVP)
  7. Timothy C Dec (CFO)
  8. Bethany Sensenig (Director)
Learn More about top insider investors at Supernus Pharmaceuticals.

Who are the major institutional investors of Supernus Pharmaceuticals?

Supernus Pharmaceuticals' top institutional investors include:
  1. Vanguard Group Inc. — 10.55%
  2. Armistice Capital LLC — 4.82%
  3. Dimensional Fund Advisors LP — 4.73%
  4. State Street Corp — 3.87%
  5. Renaissance Technologies LLC — 3.02%
  6. Geode Capital Management LLC — 2.57%
Learn More about top institutional investors of Supernus Pharmaceuticals stock.

Which major investors are selling Supernus Pharmaceuticals stock?

In the last quarter, SUPN stock was sold by these institutional investors:
  1. UBS Group AG
  2. Dimensional Fund Advisors LP
  3. Nuveen LLC
  4. Barclays PLC
  5. Armistice Capital LLC
  6. Aristotle Capital Boston LLC
  7. Man Group plc
  8. HRT Financial LP
Within the last year, company insiders that have sold Supernus Pharmaceuticals company stock include:
  1. Jack A Khattar (CEO)
  2. Frederick M Hudson (Director)
  3. Georges Gemayel (Director)
  4. Padmanabh P Bhatt (VP)
  5. Frank Mottola (SVP)
  6. Jonathan Rubin (SVP)
  7. Timothy C Dec (CFO)
Learn More investors selling Supernus Pharmaceuticals stock.

Which major investors are buying Supernus Pharmaceuticals stock?

In the last quarter, SUPN stock was bought by institutional investors including:
  1. Morgan Stanley
  2. Aberdeen Group plc
  3. MetLife Investment Management LLC
  4. ExodusPoint Capital Management LP
  5. Freestone Grove Partners LP
  6. Schroder Investment Management Group
  7. Sofinnova Investments Inc.
  8. Loomis Sayles & Co. L P